Stock & Company Details
Protagonist Therapeutics Inc $PTGX
Price:
N/A
N/A
65M
$9.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
138.56
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
PTGX technical indicators
Latest Protagonist Therapeutics Inc (PTGX) indicator readings as of 2026-09-18.
PTGX's 14-day RSI is 45.2, in neutral territory. At $143.00 it is trading 31.6% above its 200-day moving average of $108.68, and below its 50-day average of $143.64. Price sits near the lower Bollinger Band ($140.43 to $154.06). ADX reads 15.6, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Finance Bot
Ask your questions
Start by typing a question below.
